James C. Mullen - 18 Oct 2021 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
CEO, Director
Signature
/s/ James C. Mullen
Issuer symbol
EDIT
Transactions as of
18 Oct 2021
Net transactions value
-$525,033
Form type
4
Filing time
20 Oct 2021, 16:16:20 UTC
Previous filing
04 Oct 2021
Next filing
23 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale $525,033 -13,805 -19% $38.03 57,673 18 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on March 4, 2021, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 30, 2021. The sale does not represent a discretionary trade by the Reporting Person.